Endoscopic Treatment for Gastric Subepithelial Tumor
This study aimed to discuss the indications, methods, and outcomes of endoscopic therapy for gastric SETs. In addition, a simplified diagram of the category of SETs according to the therapeutic indications and an algorithm for the endoscopic management of SET is suggested.PMID:38225771 | PMC:PMC10774759 | DOI:10.5230/jgc.2024.24.e11 (Source: Journal of Gastric Cancer)
Source: Journal of Gastric Cancer - January 16, 2024 Category: Gastroenterology Authors: Chan Gyoo Kim Source Type: research
Latest Insights From Multiple Disciplinary Approaches to Manage Gastric Cancer
J Gastric Cancer. 2024 Jan;24(1):1-3. doi: 10.5230/jgc.2024.24.e8.NO ABSTRACTPMID:38225763 | PMC:PMC10774757 | DOI:10.5230/jgc.2024.24.e8 (Source: Journal of Gastric Cancer)
Source: Journal of Gastric Cancer - January 16, 2024 Category: Gastroenterology Authors: Ki Bum Park Han Hong Lee Source Type: research
Liquid Biopsy: An Emerging Diagnostic, Prognostic, and Predictive Tool in Gastric Cancer
J Gastric Cancer. 2024 Jan;24(1):4-28. doi: 10.5230/jgc.2024.24.e5.ABSTRACTLiquid biopsy, a minimally invasive procedure that causes minimal pain and complication risks to patients, has been extensively studied for cancer diagnosis and treatment. Moreover, it facilitates comprehensive quantification and serial assessment of the whole-body tumor burden. Several biosources obtained through liquid biopsy have been studied as important biomarkers for establishing early diagnosis, monitoring minimal residual disease, and predicting the prognosis and response to treatment in patients with cancer. Although the clinical applicatio...
Source: Journal of Gastric Cancer - January 16, 2024 Category: Gastroenterology Authors: Hye Sook Han Keun-Wook Lee Source Type: research
Emerging Targets for Systemic Treatment of Gastric Cancer: HER2 and Beyond
J Gastric Cancer. 2024 Jan;24(1):29-56. doi: 10.5230/jgc.2024.24.e6.ABSTRACTIn recent years, remarkable progress has been made in the molecular profiling of gastric cancer. This progress has led to the development of various molecular classifications to uncover subtype-specific dependencies that can be targeted for therapeutic interventions. Human epidermal growth factor receptor 2 (HER2) is a crucial biomarker for advanced gastric cancer. The recent promising results of novel approaches, including combination therapies or newer potent agents such as antibody-drug conjugates, have once again brought attention to anti-HER2 ...
Source: Journal of Gastric Cancer - January 16, 2024 Category: Gastroenterology Authors: In-Ho Kim Source Type: research
Current Issues in Reduced-Port Gastrectomy: A Comprehensive Review
J Gastric Cancer. 2024 Jan;24(1):57-68. doi: 10.5230/jgc.2024.24.e9.ABSTRACTReduced-port gastrectomy (RPG) includes all procedures derived from various efforts to minimize surgical invasiveness, with single-incision laparoscopic gastrectomy (SILG) being the ultimate reduced-port technique. However, there are challenges related to its feasibility, oncological validity, training, and education. This review describes the current issues and challenges, as well as the future prospects of RPG for gastric cancer. Gastrectomy, which started as an open surgery, has evolved into a laparoscopic surgery. With the advancements in lapar...
Source: Journal of Gastric Cancer - January 16, 2024 Category: Gastroenterology Authors: Jong Won Kim Source Type: research
